PLANEGG, Germany--(BUSINESS WIRE)-- Biomax Informatics AG and client KWS SAAT AG announce an extension of their software license agreement. KWS has licensed Biomax’s Pedant-Pro™ Sequence Analysis Suite to support their high-throughput analysis and annotation of plant and fungal sequences for many years.
According to Dr. Andreas Menze, head of bioinformatics at KWS, the company uses the Pedant-Pro software as one central component of their bioinformatics platform for functional and structural annotation of plant and fungal-based genomic and cDNA sequences. He explained that the Pedant-Pro system provides high-throughput analysis on a continuously increasing high number of sequences using a server cluster architecture. The analysis results are integrated into KWS data resources, made available for visualization applications and further analyses, and populate a knowledge-based platform that provides further associations and, thus, further insight for decision making, he said.
According to Menze, the system has proven its worth to KWS: “In addition to the Pedant-Pro system’s broad range of functionality and diverse integrated databases, the software has a very user-friendly GUI, which allows even staff with little IT experience to use the system efficiently.”
"Such a review after so many years from one of our longtime clients is the best proof of long term customer satisfaction in terms of usability, analysis reliability and scientific excellence. The Pedant-Pro system has been adapted continuously to address the needs of the ever-increasing amounts of sequences generated by next generation sequencing technologies. A tight integration of the Pedant-Pro system into our BioXM™ Knowledge Management Environment is the most recent and logical step in this process. We are pleased KWS has confirmed their satisfaction by extending our collaboration,” said Dr. Philipp Krubasik, Director of Key Accounts at Biomax.
Biomax provides computational solutions for better decision making and knowledge management in the life sciences. They help customers generate value by integrating information from proprietary and public resources to enable a knowledge-based approach to developing innovative life science products. Biomax’s worldwide customer community includes companies and research organizations that are successful in drug discovery, diagnostics, fine chemicals, food and plant production. Further information is available at www.biomax.com.